Description

RABIFINITY-L Capsules contain a combination of Rabeprazole 20 mg and Levosulpiride 75 mg (Sustained Release), formulated for the effective management of acid-related gastrointestinal disorders and motility issues. Rabeprazole is a proton pump inhibitor (PPI) that reduces excess gastric acid secretion, helping relieve acidity, heartburn, and acid reflux, while Levosulpiride is a prokinetic agent that improves gastrointestinal motility and helps relieve symptoms such as bloating, nausea, and early satiety.

This combination is commonly prescribed for gastroesophageal reflux disease (GERD), functional dyspepsia, acid reflux, gastritis, and delayed gastric emptying. The sustained-release formulation of Levosulpiride ensures prolonged action, providing better symptom control and improved digestive comfort when used as directed.

Key Highlights:

• Contains Rabeprazole 20 mg + Levosulpiride 75 mg (SR)

• Reduces excess stomach acid and acidity symptoms

• Improves gastric motility and digestion

• Helps relieve bloating, nausea, and heartburn

• Effective in GERD and functional dyspepsia

• Sustained-release formulation for prolonged relief

• To be used under medical supervision

Dosage and duration should be followed strictly as prescribed by the physician to ensure safe and effective treatment.

If you want Monopoly PCD Franchise In Panchkula then please contact us.